Focused on innovation and creation
Agathos’ disciplined strategy will focus on innovation and creation. There are those who are passionate about the use of aborted fetal tissue and are zealous in their desire to end the practice. This leads them to spend time and energy arguing that products manufactured with these cells are unsafe or lack efficacy. Unfortunately, in many cases the data are suspect, and this negatively impacts their credibility and others. Even if the data are compelling, their politics will always subject them to claims of bias and lack of objectivity. We recognize that cell lines obtained from aborted fetal tissue (AFT) have produced products that are safe, efficacious, and saved lives. Their use in research and development has contributed to many products that we take for granted and have improved human health. We will not waste time debating these facts.
We cannot put the genie back into the bottle—the best way to address the problem is with a better genie. Agathos’ strategy, the same as any company, to make better products, is clear and uncontroversial. Even those who have no ethical concerns recognize it is better from a pure business perspective to remove reasons for consumers not to purchase your product. And if consumers are presented with a better product—however they define “better”—their choice is also clear and uncontroversial.